FDA NDC Directory · JSON-LD · Markdown

Tresiba

NDC 0169-2662 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameinsulin degludec
Labeler / ManufacturerNovo Nordisk
Marketing categoryBiologic License Application · App BLA203314
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsINSULIN DEGLUDEC (100 U/mL)
Marketing started20181121
Package count2

External sources

Source: openFDA. Public-domain (CC0).